Diaphragmatic Atrophy Related to Mechanical Ventilation (ECHODIAPH)

Ultrasound Observation of Diaphragmatic Atrophy Related to Mechanical Ventilation A Prospective Monocentric Study in Intensive Care Unit

Ventilatory support during critical phase result in inactivity of respiratory muscles especially diaphragm muscle. These inactivity also result in change of contractile capability and quick muscular atrophy.

The aim of the study is to visualize the evolution of diaphragm thickness by echography during Mechanical Ventilation for patients with septic shock or acute respiratory distress syndrome and to compare with the evolution for patients under non-invasive ventilation and those with spontaneous ventilation. Measurements will be performed at day 1, day 5 and day 10 (if patient still under a mode of ventilation or in the unit).

The evolution of diaphragm thickness will also be compared to pectoralis muscle atrophy, which is not involved in ventilation, in order to assess respective effect of ventilatory inactivity and undernutrition linked to intensive care.

Study Overview

Study Type

Interventional

Enrollment (Actual)

97

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥18 years old
  • Group 1 : under Mechanical Ventilation (time of Mechanical Ventilation for at least 5 days)
  • Group 2 : under Non-invasive Ventilation
  • Group 3 : Spontaneous Ventilation
  • Non opposition of patient (Groups 2 and 3) or non-opposition of patient family member (Group 1)

Exclusion Criteria:

  • Known diaphragmatic paralysis
  • Neurologic pathology with motor deficit
  • Pregnancy or breast-feeding woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mechanical Ventilation

Evolution over time of Diaphragmatic and Pectoralis muscle atrophy under Mechanical Ventilation

Interventions :

  • Ultrasound of the right diaphragm
  • Ultrasound of the pectoral muscle
  • Neuromyopathy score
  • Respiratory performances
An ultrasound of the right diaphragm will be performed on day 1, day 3, day 5 and day 10
An ultrasound of the pectoral muscle will be performed on day 1, day 3, day 5 and day 10
A neuromyopathy score will be assessed on the extubation day
An assessment of the respiratory performances will be done on the extubation day, including higher expiratory pressure, higher inspiratory pressure, and occlusion pressure
Active Comparator: Non-invasive Ventilation

Evolution over time of Diaphragmatic and Pectoralis muscle atrophy under Non-invasive Ventilation

Interventions :

  • Ultrasound of the right diaphragm
  • Ultrasound of the pectoral muscle
  • Neuromyopathy score
  • Respiratory performances
An ultrasound of the right diaphragm will be performed on day 1, day 3, day 5 and day 10
An ultrasound of the pectoral muscle will be performed on day 1, day 3, day 5 and day 10
A neuromyopathy score will be assessed on the extubation day
An assessment of the respiratory performances will be done on the extubation day, including higher expiratory pressure, higher inspiratory pressure, and occlusion pressure
Active Comparator: Spontaneous Ventilation

Evolution over time of Diaphragmatic and Pectoralis muscle atrophy under Spontaneous Ventilation

Interventions :

  • Ultrasound of the right diaphragm
  • Ultrasound of the pectoral muscle
  • Neuromyopathy score
  • Respiratory performances
An ultrasound of the right diaphragm will be performed on day 1, day 3, day 5 and day 10
An ultrasound of the pectoral muscle will be performed on day 1, day 3, day 5 and day 10
A neuromyopathy score will be assessed on the extubation day
An assessment of the respiratory performances will be done on the extubation day, including higher expiratory pressure, higher inspiratory pressure, and occlusion pressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from day 1 diaphragm thickness at day 3 and day 5
Time Frame: 1 day, 3 days and 5 days after introduction of Mechanical Ventilation
Diaphragm thickness measured by ultrasound
1 day, 3 days and 5 days after introduction of Mechanical Ventilation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diaphragm thickness measured by ultrasound
Time Frame: 10 days after introduction of Mechanical Ventilation
10 days after introduction of Mechanical Ventilation
Type of ventilatory support
Time Frame: 10 days after start of ventilatory support
Define which type of ventilatory support is used (mechanical ventilation, non-invasive ventilation, or spontaneous ventilation)
10 days after start of ventilatory support
Ventilatory mode
Time Frame: 10 days after start of ventilatory support
Ventilatory mode (controlled ventilation, pressure support ventilation)
10 days after start of ventilatory support
Pectoralis muscle thickness measured by ultrasound
Time Frame: 10 days after start of ventilatory support
To compare the importance of this atrophy to those of diaphragmatic muscle
10 days after start of ventilatory support
Diaphragmatic strength
Time Frame: intraoperative
Relation between diaphragmatic atrophy and decrease of diaphragmatic strength
intraoperative
Early or late extubation failure rate (extubation performed before or after 48 hours)
Time Frame: The last day of hospitalisation
Relation between diaphragmatic atrophy importance and premature (<48h) or late extubation failure
The last day of hospitalisation
MRC score (Medical Research Council)
Time Frame: intraoperative
Relation between diaphragmatic atrophy and decrease of diaphragmatic strength
intraoperative
Length of ventilation in hours
Time Frame: 10 days after start of ventilatory support
10 days after start of ventilatory support
Drug administration
Time Frame: 10 days after start of ventilatory support
Presence of drug administration such as curare, corticoid or sedative. If yes : number of days with treatment
10 days after start of ventilatory support
Total positive end expiratory pressure
Time Frame: 10 days after start of ventilatory support
10 days after start of ventilatory support
External positive end expiratory pressure
Time Frame: 10 days after start of ventilatory support
10 days after start of ventilatory support
Respiratory rate
Time Frame: 10 days after start of ventilatory support
10 days after start of ventilatory support
Highest inspiratory pressure level
Time Frame: 10 days after start of ventilatory support
10 days after start of ventilatory support
Highest expiratory pressure level
Time Frame: 10 days after start of ventilatory support
10 days after start of ventilatory support
Volume of exhaled air
Time Frame: 10 days after start of ventilatory support
10 days after start of ventilatory support

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2013

Primary Completion (Actual)

December 17, 2015

Study Completion (Actual)

December 22, 2015

Study Registration Dates

First Submitted

April 29, 2016

First Submitted That Met QC Criteria

May 9, 2016

First Posted (Estimated)

May 10, 2016

Study Record Updates

Last Update Posted (Actual)

April 4, 2024

Last Update Submitted That Met QC Criteria

April 3, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SJSL12013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Septic Shock

Clinical Trials on Ultrasound

Subscribe